BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26184999)

  • 1. Tyrosine kinase inhibitor tyrphostin AG490 triggers both apoptosis and autophagy by reducing HSF1 and Mcl-1 in PEL cells.
    Granato M; Chiozzi B; Filardi MR; Lotti LV; Di Renzo L; Faggioni A; Cirone M
    Cancer Lett; 2015 Oct; 366(2):191-7. PubMed ID: 26184999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis.
    Alas S; Bonavida B
    Clin Cancer Res; 2003 Jan; 9(1):316-26. PubMed ID: 12538484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flavopiridol disrupts STAT3/DNA interactions, attenuates STAT3-directed transcription, and combines with the Jak kinase inhibitor AG490 to achieve cytotoxic synergy.
    Lee YK; Isham CR; Kaufman SH; Bible KC
    Mol Cancer Ther; 2006 Jan; 5(1):138-48. PubMed ID: 16432172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of JAK kinase activity enhances Fas-mediated apoptosis but reduces cytotoxic activity of topoisomerase II inhibitors in U266 myeloma cells.
    Oshiro MM; Landowski TH; Catlett-Falcone R; Hazlehurst LA; Huang M; Jove R; Dalton WS
    Clin Cancer Res; 2001 Dec; 7(12):4262-71. PubMed ID: 11751528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a JAK inhibitor, AG490, on proliferation and apoptosis of human nasopharyngeal carcinoma cell line CNE-2Z.
    Wu MH; Chen XY; Cai KR
    Ai Zheng; 2009 Jan; 28(1):24-8. PubMed ID: 19448411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma.
    Aoki Y; Feldman GM; Tosato G
    Blood; 2003 Feb; 101(4):1535-42. PubMed ID: 12393476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abrogation of constitutive STAT3 activity sensitizes human hepatoma cells to TRAIL-mediated apoptosis.
    Kusaba M; Nakao K; Goto T; Nishimura D; Kawashimo H; Shibata H; Motoyoshi Y; Taura N; Ichikawa T; Hamasaki K; Eguchi K
    J Hepatol; 2007 Oct; 47(4):546-55. PubMed ID: 17602782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells.
    Eriksen KW; Kaltoft K; Mikkelsen G; Nielsen M; Zhang Q; Geisler C; Nissen MH; Röpke C; Wasik MA; Odum N
    Leukemia; 2001 May; 15(5):787-93. PubMed ID: 11368440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capsaicin triggers immunogenic PEL cell death, stimulates DCs and reverts PEL-induced immune suppression.
    Granato M; Gilardini Montani MS; Filardi M; Faggioni A; Cirone M
    Oncotarget; 2015 Oct; 6(30):29543-54. PubMed ID: 26338963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gö6976, a FLT3 kinase inhibitor, exerts potent cytotoxic activity against acute leukemia via inhibition of survivin and MCL-1.
    Yoshida A; Ookura M; Zokumasu K; Ueda T
    Biochem Pharmacol; 2014 Jul; 90(1):16-24. PubMed ID: 24735609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fisetin, a dietary flavonoid, induces apoptosis of cancer cells by inhibiting HSF1 activity through blocking its binding to the hsp70 promoter.
    Kim JA; Lee S; Kim DE; Kim M; Kwon BM; Han DC
    Carcinogenesis; 2015 Jun; 36(6):696-706. PubMed ID: 25840992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression.
    Epling-Burnette PK; Liu JH; Catlett-Falcone R; Turkson J; Oshiro M; Kothapalli R; Li Y; Wang JM; Yang-Yen HF; Karras J; Jove R; Loughran TP
    J Clin Invest; 2001 Feb; 107(3):351-62. PubMed ID: 11160159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrphostin B42 inhibits IL-12-induced tyrosine phosphorylation and activation of Janus kinase-2 and prevents experimental allergic encephalomyelitis.
    Bright JJ; Du C; Sriram S
    J Immunol; 1999 May; 162(10):6255-62. PubMed ID: 10229872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of STAT3 in ischemic preconditioning.
    Hattori R; Maulik N; Otani H; Zhu L; Cordis G; Engelman RM; Siddiqui MA; Das DK
    J Mol Cell Cardiol; 2001 Nov; 33(11):1929-36. PubMed ID: 11708838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells.
    Real PJ; Sierra A; De Juan A; Segovia JC; Lopez-Vega JM; Fernandez-Luna JL
    Oncogene; 2002 Oct; 21(50):7611-8. PubMed ID: 12400004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The JAK2 inhibitor AG490 predominantly abrogates the growth of human B-precursor leukemic cells with 11q23 translocation or Philadelphia chromosome.
    Miyamoto N; Sugita K; Goi K; Inukai T; Lijima K; Tezuka T; Kojika S; Nakamura M; Kagami K; Nakazawa S
    Leukemia; 2001 Nov; 15(11):1758-68. PubMed ID: 11681418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin triggers apoptosis in PEL cells and alters bortezomib-induced Unfolded Protein Response increasing its cytotoxicity and inhibiting KSHV lytic cycle activation.
    Granato M; Gilardini Montani MS; Romeo MA; Santarelli R; Gonnella R; D'Orazi G; Faggioni A; Cirone M
    Cell Signal; 2017 Dec; 40():239-247. PubMed ID: 28964970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells.
    Rahaman SO; Harbor PC; Chernova O; Barnett GH; Vogelbaum MA; Haque SJ
    Oncogene; 2002 Dec; 21(55):8404-13. PubMed ID: 12466961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of constitutively activated Jak3 and induction of apoptosis in NALM-6 cell line].
    Hu W; Zhang C; Zhang P; Wei D; Zhao Z; Cai M
    Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):25-7. PubMed ID: 12599420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent STAT3 activation is associated with Mcl-1 expression in nasal NK-cell lymphoma.
    Tsutsui M; Yasuda H; Suto H; Imai H; Isobe Y; Sasaki M; Kojima Y; Oshimi K; Sugimoto K
    Int J Lab Hematol; 2010 Aug; 32(4):419-26. PubMed ID: 19968719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.